4.3 Review

National human embryo and embryoid research policies: a survey of 22 top research-intensive countries

Journal

REGENERATIVE MEDICINE
Volume 15, Issue 7, Pages 1905-1917

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/rme-2019-0138

Keywords

embryoids; embryos; human embryonic stem cells; human embryo research; law; pluripotent stem cells; policy; public policy; science policy; synthetic embryos

Funding

  1. Greenwall Foundation `Making a Difference' grant
  2. Baker Institute Center for Health and Biosciences

Ask authors/readers for more resources

Research using human embryos and embryoids has expanded in recent years due to technological advances. Surveying laws and guidelines among the top research and development (R&D) investing nations highlights existing barriers to expanding this area of research. Of the 22 nations surveyed, we found 12 countries with a 14-day limit, one with a seven-day limit, five with prohibitions and four without national laws or guidelines that limit or prohibit human embryo research. Sixteen national laws or guidelines define an embryo or related entities, with five nations limiting human embryoid research. Other laws are ambiguous in relation to embryoid research, leave unanswered questions regarding what research is permitted or restricted and need additional clarity for researchers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available